A Novel Approach to Antigen-Specific Deletion of CTL with Minimal Cellular Activation Using α3 Domain Mutants of MHC Class I/Peptide Complex
Xiao-Ning Xu(Imperial College London), Gavin Screaton(University of Oxford), P. Rod Dunbar(Memorial Sloan Kettering Cancer Center), Victor Appay(Inserm), Christopher S. Hourigan(National Heart Lung and Blood Institute), Sabrina Tafuro(John Radcliffe Hospital), Scott R. Burrows(Australian National University), Vincenzo Cerundolo(John Radcliffe Hospital), Juthathip Mongkolsapaya(John Radcliffe Hospital), Nan Chen(John Radcliffe Hospital), Jennifer H. Cox(John Radcliffe Hospital), Marco A. Purbhoo(John Radcliffe Hospital), Andrew J. McMichael(Nuffield Orthopaedic Centre), Ute‐Christiane Meier(John Radcliffe Hospital)
Cited by 73
Related Papers
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k
HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function
|The Journal of Experimental Medicine|2000|864
The immune response during acute HIV-1 infection: clues for vaccine development
|Nature reviews. Immunology|2009|846